Terri B. Sebree
2015
In 2015, Terri B. Sebree earned a total compensation of $2.6M as President at Zynerba Pharmaceuticals, a 318% increase compared to previous year.
Compensation breakdown
| Bonus | $257,122 |
|---|---|
| Salary | $400,000 |
| Stock Awards | $1,931,807 |
| Other | $15,418 |
| Total | $2,604,347 |
Sebree received $1.9M in stock awards, accounting for 74% of the total pay in 2015.
Sebree also received $257.1K in bonus, $400K in salary and $15.4K in other compensation.
Rankings
In 2015, Terri B. Sebree's compensation ranked 3,676th out of 13,638 executives tracked by ExecPay. In other words, Sebree earned more than 73.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,676 out of 13,638 | 73rd |
Division Manufacturing | 1,344 out of 5,187 | 74th |
Major group Chemicals And Allied Products | 488 out of 1,857 | 74th |
Industry group Drugs | 389 out of 1,531 | 75th |
Industry Pharmaceutical Preparations | 306 out of 1,179 | 74th |
Source: SEC filing on April 13, 2016.
Sebree's colleagues
We found three more compensation records of executives who worked with Terri B. Sebree at Zynerba Pharmaceuticals in 2015.
News
Zynerba Pharmaceuticals CEO Armando Anido's 2022 pay slips 15% to $1.9M
April 21, 2023
Zynerba Pharmaceuticals CEO Armando Anido's 2021 pay jumps 49% to $2.2M
April 25, 2022
Zynerba Pharmaceuticals CEO Armando Anido's 2020 pay rises 8% to $1.5M
April 21, 2021
Zynerba Pharmaceuticals CEO Armando Anido's 2019 pay falls 32% to $1.4M
April 23, 2020
Zynerba Pharmaceuticals CEO Armando Anido's 2018 pay slips 18% to $2M
April 25, 2019